Skip to main content

Johnson & Johnson 3D Printing Center of Excellence

PlatformNew Brunswick, NJ, USAFounded 2017· One of 245 Platform companies tracked by AMPulse

An internal innovation hub that integrates 3D printing across Johnson & Johnson's medical devices, pharmaceuticals, and consumer health sectors to enable personalized healthcare solutions like custom implants, surgical tools, anatomical models, and bioprinted tissues.

CEO / Founder
Sam Onukuri
Team Size
51-200
Stage
Active

Technology & Products

Key Products

Customized knee implants; Titanium alloy implants for cancer patients; Trumatch® Graft Cage – Long Bone; Bioprinted knee meniscus tissue prototypes; Surgical tools and anatomical models

Technological Advantage

Proprietary network of collaborative labs with top universities (e.g., Trinity College Dublin, University of Miami) focusing on 3D bioprinting and advanced materials, enabling rapid prototyping and commercialization of personalized healthcare solutions.

Differentiation

Value Proposition

Reduces patient pain and recuperation time by up to 50% through customized knee implants and surgical tools, while enabling on-demand production of medical devices and bioprinted tissues for faster commercialization.

How They Differentiate

Integrates 3D printing across all J&J business sectors (medical devices, pharma, consumer health) with a focus on personalized solutions, unlike competitors focused solely on hardware or services; leverages J&J's regulatory expertise and global supply chain for faster market entry.

Market & Competition

Target Customers

Surgeons, hospitals, healthcare providers, patients requiring personalized medical solutions

Industry Verticals

Medical Devices; Pharmaceuticals; Consumer Health

Competitors

Stryker (3D-printed medical implants); 3D Systems (medical 3D printing and bioprinting); Materialise (medical software and 3D printing services)

Growth & Milestones

Growth Metrics

The 3D Printing Center of Excellence has enabled over 100 personalized medical devices and implants, reduced surgical planning time by 30% for complex cases, and supported development of bioprinted tissues for pharmaceutical testing.

Major Milestones

Established 3D Printing Center of Excellence led by Sam Onukuri; Debut of customized surgical tools for nationwide hospital use (2019-2020); Expansion into bioprinting for orthopedics and regenerative medicine; Collaboration with Aspect Biosystems on bioprinted knee tissues; Launch of Trumatch® Graft Cage – Long Bone device

Notable Customers

Prisma Health (VESper device manufacturing); U.S. hospitals (customized surgical tools)